Replies to post #4796 on Halozyme Therapeutics Inc (HALO)

[DrStockonomics]

It has been a bumpy ride for HALO. I believe mid $7's to $25 and back down again. Still long on them though and believe the science to be good. HALO will see $25 again and hopefully more.

[XenaLives]

Quite a few individual biotechs are in the same situation or worse. My theory is that this is a final shakeout before the sector matures.

Dr - an expected response but the fact is that over the past ten years the biotech index is up 3 times but HALO is static.